Acid suppression as treatment for NSAID-related peptic ulcers
- PMID: 1962615
Acid suppression as treatment for NSAID-related peptic ulcers
Similar articles
-
Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.N Engl J Med. 1998 Jul 30;339(5):350-1. N Engl J Med. 1998. PMID: 9696652 No abstract available.
-
Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.Am J Gastroenterol. 2000 Feb;95(2):513-9. doi: 10.1111/j.1572-0241.2000.01777.x. Am J Gastroenterol. 2000. PMID: 10685760
-
Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.N Engl J Med. 1998 Jul 30;339(5):349-50; author reply 350-1. N Engl J Med. 1998. PMID: 9696650 No abstract available.
-
Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.J Physiol Pharmacol. 1995 Mar;46(1):3-16. J Physiol Pharmacol. 1995. PMID: 7599335 Review.
-
Role of acid suppressants in prophylaxis of NSAID damage.Best Pract Res Clin Gastroenterol. 2001 Jun;15(3):433-45. doi: 10.1053/bega.2001.0192. Best Pract Res Clin Gastroenterol. 2001. PMID: 11403537 Review.
Cited by
-
Nonsteroidal antiinflammatory drugs and lower gastrointestinal bleeding.Dig Dis Sci. 1993 Sep;38(9):1619-23. doi: 10.1007/BF01303169. Dig Dis Sci. 1993. PMID: 8359073
-
Over-the-counter histamine H2-receptor antagonists. How will they affect the treatment of acid-related diseases?Drugs. 1994 Jan;47(1):1-11. doi: 10.2165/00003495-199447010-00001. Drugs. 1994. PMID: 7510616 Review. No abstract available.
-
Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.Gut. 1998 Sep;43(3):334-41. doi: 10.1136/gut.43.3.334. Gut. 1998. PMID: 9863477 Free PMC article.
-
Effect of study protocol on the interactions between cimetidine and paracetamol in man.Eur J Drug Metab Pharmacokinet. 1999 Apr-Jun;24(2):159-62. doi: 10.1007/BF03190363. Eur J Drug Metab Pharmacokinet. 1999. PMID: 10510744
-
Prediction of Omeprazole Pharmacokinetics and its Inhibition on Gastric Acid Secretion in Humans Using Physiologically Based Pharmacokinetic-Pharmacodynamic Model Characterizing CYP2C19 Polymorphisms.Pharm Res. 2023 Jul;40(7):1735-1750. doi: 10.1007/s11095-023-03531-y. Epub 2023 May 24. Pharm Res. 2023. PMID: 37226024
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical